Bill Gates has already withdrawn his fortune from mRNA technology in 2021
Commentaries by
Dr. Robert Gorter, MD, PhD.
December 17th, 2023
© Report24.news
De shares of Pfizer are falling and falling, the trend continues to go down. The market seems to sense that the big vaccine scam will be exposed at some point soon and that legal consequences will follow. This could have such major consequences that the survival of all pharmaceutical giants involved is jeopardized. Excitingly, by the end of 2021, Bill Gates had invested large sums in these companies and significantly increased his wealth – but then withdrew the profits, writes Report24.
Gates initially held 1,038,674 shares in BioNTech but withdrew most of them in the third quarter of 2021. He sold 86 percent of his shares and kept only 148,674 shares. If you look at the image below, you will see how perfectly his sale was executed. The dot indicates the date. The value of his remaining shares had already fallen by 42 percent in 2021. Oof! Just “luck” again, right?
At the same time, it is very interesting to see that Gates withdrew a huge number of shares from VIR Biotechnology. He reduced his stake there by 2,100,000 shares or 76 percent of his total stake.
The chart on 13f.info also shows at what point Gates really got into the stock business. Things went downhill from the third quarter of 2021. Partly because the companies in which the Bill and Melinda Gates Foundation invested all lost value, but mainly because the profits were withdrawn and probably invested elsewhere. The stock market investment shown here fell from $691 million to currently approximately $84 million.
The 13F portfolio shown here is a tool of the U.S. Securities and Exchange Commission. However, there are other presentations that are a little more extensive. You can take a more in-depth look at Bill Gates’ portfolio at Valuesider.com. And above all, historical data dating back to the years before the coronavirus era is available here. This graph shows it: From quarter 3 of 2022, Billy was again particularly diligent in his stock market investments – or was again sensationally lucky. 17.6 billion in stock market assets in 2022 became a comfortable 42 billion in 2023 – and dropped to 39 billion US dollars at the end.
However, the reason for the moves should be further investigated as they could be the result of both purchases and price gains. The same picture emerges on other major platforms. The Bill and Melinda Gates Foundation currently does not invest any relevant amounts in companies involved in the production or distribution of mRNA technology. The most important healthcare investment that can be traced over the years is Schrödinger Inc., an international scientific software company specializing in the development of computer tools and software for drug discovery and materials science.
The fact is that Pfizer and Biontech are no longer relevant to Bill Gates’ total assets. The business is done, the rest is irrelevant. Quarter 3 of 2023 is reported as Pfizer Inc – total value US$2.25 million. Valuesider no longer reports shares in BioNTech or Moderna. Moreover, “Beyond Meat”, the artificial meat company, is no longer reported.
However, shares are still possible in a roundabout way: a good fifth of Gates’ billion-dollar fortune is parked in Berkshire Hathaway Inc. shares. worth $7.9 billion. This is a holding company that owns or has interests in numerous other companies – mainly insurance companies. For some time now, the value of Microsoft shares has also risen enormously: Bill Gates now has USD 12.4 billion there.
Regarding Pfizer’s profit-taking, the Ron Paul Institute describes the events from 2019 to 2021 as follows:
In September 2019, just a few months before the COVID hysteria swept the world, the Gates Foundation secured its stake in the Pfizer vaccine partner through a pre-IPO stock transaction with an agreed purchase price of USD 18.10 per share. With an average sales price of approximately USD 300 per share in the third quarter of 2021, this means that the Gates Foundation received approximately USD 260 million in cash from the sale, with USD 242 million being untaxed profits because the money was invested through the Foundation. And that doesn’t take into account the additional 2 million shares the Gates Foundation previously sold from its original pre-IPO equity investment. When sold in the third quarter of 2021, the Gates Foundation achieved a return of more than 15 times its original investment.
The following quarter, Gates sold 1.4 million shares of Curevac, another Germany-based mRNA company that works with several mRNA vaccine makers, raising an estimated $50 million.
After selling his shares in the mRNA company, Gates changed his mind about the technology behind the alleged and globally touted “miracle drug.” Gates, who once claimed that vaccination with mRNA vaccines had a preventive effect and “helped the heart,” from then on began to criticize the experimental injections.
Then, in early 2023, Bill Gates expressed the following opinion (and we bet you haven’t heard about it in the mainstream):
We also need to solve the three problems of [mRNA] vaccines. Current vaccines do not block infections. They are not broad-based, so as new variants emerge you lose protection, and they have a very short duration of action, especially in the people who matter, which are old people.
Reckless to criminal politicians, for example in Austria, still recommend mRNA vaccination today – regardless of the fact that it does not work, its effect is reversed and terrible side effects occur, including death.